PMMNG member Phil Falkowitz started taking Revlimid (lenalidomide) way back in 2001, during the Phase 1 clinical trial of Revlimid. That trial went well for him (and for Revlimid).
What: Audio (59:29) and transcript from webinar
When: Monday April 16, 2018
When: Wednesday, April 18, 2018 Noon - 1:00 PM ET
More Info: http://www.lls.org/events/clinical-trials-for-blood-cancers-how-can-participating-in-a-clinical-trial-help-me
What: Transcript and Video from webinar panel discussion
When: Thursday June 20, 2018
We've got a few news items to pass along: